相关产品推荐更多 >

TGFB1 抗体-TGFB1 Antibody
¥22
GTPBP1 抗体-GTPBP1 Antibody
¥22
Anti-EPS8L1 Antibody/Anti-EPS8L1 Antibody/Anti-EPS8L1 Antibody
询价
TWIST1纯化的MaxPab兔源多克隆抗体
询价
Carboxymethylenebutenolidase Homolog (CMBL) Antibody (FITC)/Carboxymethylenebutenolidase Homolog (CMBL) Antibody (FITC)/Carboxymethylenebutenolidase Homolog (CMBL) Antibody (FITC)
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
A recombinant protein fragment from the C-terminal region of human EMAP II was used as the immunogen for this antibody.
- 保存条件:
Aliquot and Store at -20℃
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 宿主:
兔
- 应用范围:
WB
- 抗体英文名:
EMAP II Antibody
- 抗体名:
EMAP II Antibody
- 规格:
100ug
EMAP II 抗体,EMAP II Antibody,EMAP II 抗体,EMAP II Antibody
产品名称:EMAP II 抗体-EMAP II Antibody
产品货号:PSI-33-049-100ug
产品规格:100ug
背景资料:EMAP II (Endothelial monocyte-activating polypeptide 2) is a pro-inflammatory cytokine and participant in apoptotic cell death. It is synthesized as a precursor (pro-EMAP II), lacking a secretion signal peptide. In apoptotic cells, the ~34 kDa pro-form of EMAP II is cleaved by Caspase-7 (and Caspase-3 to a lesser extent) at aspartate 144 to its mature, ~20 kDa form. The mature form of EMAP II has been found to have many different functions. In vivo, it recruits leukocytes to the site of apoptotic cell death. In vitro it has been shown to activate endothelial cells (and the release of von Willebrand factor, E-selectin and P-selectin), neutrophils, and induces macrophage expression of TNFa and TF (tissue factor). EMAP II is also a possible biomarker for brain injury, having been found to be differentially expressed in two types: traumatic injury shows an increase and ischemic injury shows a decrease in EMAP II expression (Dave, et al, 2014).
保存建议:EMAP II 抗体-EMAP II AntibodyAliquot and Store at -20℃
应用类型:WB
点击:EMAP II 抗体-EMAP II Antibody查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料






